MYUNGMOON Pharm co.,Ltd (017180.KS)
017180.KS Stock Price Chart
Explore MYUNGMOON Pharm co.,Ltd interactive price chart. Choose custom timeframes to analyze 017180.KS price movements and trends.
017180.KS Company Profile
Discover essential business fundamentals and corporate details for MYUNGMOON Pharm co.,Ltd (017180.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
10 Jul 2008
Employees
282.00
Website
https://www.mmpharm.co.krCEO
Kyu-Huok Lee
Description
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.
017180.KS Financial Timeline
Browse a chronological timeline of MYUNGMOON Pharm co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
EPS came in at ₩103.00 , while revenue for the quarter reached ₩48.76B .
Earnings released on 15 May 2025
EPS came in at -₩58.00 , while revenue for the quarter reached ₩45.87B .
Earnings released on 19 Feb 2025
EPS came in at ₩15.20 , while revenue for the quarter reached ₩49.15B .
Earnings released on 14 Nov 2024
EPS came in at -₩24.00 , while revenue for the quarter reached ₩46.98B .
Earnings released on 14 Aug 2024
EPS came in at -₩45.77 , while revenue for the quarter reached ₩46.08B .
Earnings released on 14 May 2024
EPS came in at -₩36.21 , while revenue for the quarter reached ₩44.23B .
Earnings released on 20 Mar 2024
EPS came in at -₩120.25 , while revenue for the quarter reached ₩42.85B .
Earnings released on 14 Nov 2023
EPS came in at -₩27.94 , while revenue for the quarter reached ₩43.21B .
Earnings released on 11 Aug 2023
EPS came in at -₩4.05 , while revenue for the quarter reached ₩43.51B .
Earnings released on 15 May 2023
EPS came in at ₩137.04 , while revenue for the quarter reached ₩39.98B .
Earnings released on 31 Mar 2023
EPS came in at ₩11.25 , while revenue for the quarter reached ₩40.00B .
Earnings released on 30 Sept 2022
EPS came in at ₩2.78 , while revenue for the quarter reached ₩36.88B .
Earnings released on 30 Jun 2022
EPS came in at ₩64.37 , while revenue for the quarter reached ₩40.78B .
Earnings released on 31 Mar 2022
EPS came in at ₩28.55 , while revenue for the quarter reached ₩34.50B .
Earnings released on 16 Feb 2022
EPS came in at -₩231.57 , while revenue for the quarter reached ₩35.36B .
Earnings released on 15 Nov 2021
EPS came in at -₩4.00 , while revenue for the quarter reached ₩35.20B .
Earnings released on 17 Aug 2021
EPS came in at ₩18.00 , while revenue for the quarter reached ₩35.72B .
Earnings released on 14 May 2021
EPS came in at ₩18.00 , while revenue for the quarter reached ₩31.48B .
Earnings released on 19 Mar 2021
EPS came in at -₩288.64 , while revenue for the quarter reached ₩32.20B .
Earnings released on 16 Nov 2020
EPS came in at -₩174.00 , while revenue for the quarter reached ₩32.15B .
017180.KS Stock Performance
Access detailed 017180.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.